Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Monday's Pre-Market Session

Author: Benzinga Insights | March 11, 2024 09:05am

Gainers

  • TC BioPharm (Holdings) (NASDAQ:TCBP) shares increased by 74.5% to $1.85 during Monday's pre-market session. The company's market cap stands at $4.4 million.
  • Dyadic International (NASDAQ:DYAI) stock rose 21.73% to $1.68. The company's market cap stands at $48.4 million.
  • Mesoblast (NASDAQ:MESO) shares rose 19.53% to $2.57. The company's market cap stands at $260.8 million.
  • Aprea Therapeutics (NASDAQ:APRE) stock moved upwards by 15.28% to $8.22. The market value of their outstanding shares is at $30.7 million.
  • Talphera (NASDAQ:TLPH) stock increased by 13.77% to $1.28. The market value of their outstanding shares is at $21.7 million. The company's, Q4 earnings came out 3 days ago.
  • Graphite Bio (NASDAQ:GRPH) stock rose 12.1% to $3.52. The company's market cap stands at $204.9 million.

Losers

  • Ainos (NASDAQ:AIMD) shares fell 15.6% to $1.73 during Monday's pre-market session. The company's market cap stands at $8.0 million. As per the press release, Q4 earnings came out yesterday.
  • Nexalin Technology (NASDAQ:NXL) shares decreased by 11.64% to $0.43. The market value of their outstanding shares is at $3.1 million.
  • Fortrea Holdings (NASDAQ:FTRE) shares fell 10.32% to $33.03. The market value of their outstanding shares is at $2.9 billion. As per the press release, Q4 earnings came out today.
  • Avenue Therapeutics (NASDAQ:ATXI) stock fell 9.64% to $0.17. The company's market cap stands at $6.4 million.
  • Indaptus Therapeutics (NASDAQ:INDP) stock fell 9.31% to $1.95. The market value of their outstanding shares is at $16.3 million.
  • Yield10 Bioscience (NASDAQ:YTEN) shares fell 7.69% to $0.25. The company's market cap stands at $2.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AIMD APRE ATXI DYAI FTRE GRPH INDP MESO NXL TCBP TLPH YTEN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist